Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
  • 8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...
  • 8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD
  • 8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...
  • 8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...
  • 8/4/2025Novartis Submits Zolgensma for Approval in China with Priority Review ...
  • 8/4/2025Alphamab's JSKN022 ADC Clears Major Regulatory Hurdle, Highlights Prec...
  • 8/4/2025China Grants First-Time Approval to Eight New Drugs in July 2025
  • 8/2/2025PD‑L1×VEGF Bispecific from ImmuneOnco Shows Strong Efficacy in China...
  • 8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...
  • 8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...
  • 7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...
  • 7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China
  • 7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...
  • 7/30/2025China Approves Domestic CD19 CAR-T Therapy Hengkailai
  • 7/30/2025SPH Biothera Receives NMPA Clearance for CAR-T Therapy Targeting Refra...
  • 7/29/2025Pfizer Launches Landmark Pneumococcal Vaccine Trial in China, Pioneeri...
  • 7/29/2025Innovent Wins NMPA Clearance for IBI363 in Two New Cancer Trials
  • 7/29/2025LENZ Moves Toward Approval in China with LNZ100 Submission
  • 7/29/2025Bayer Files HER2+ Lung Cancer Drug in China
  • 7/28/2025Antengene's XPOVIO® Wins Third Approval in China for Multiple Myeloma
  • 7/28/2025China Medical System Gains NMPA Acceptance for Alzheimer's Drug ZUNVEY...
  • 7/28/2025Pierre Fabre Scores China Approval for Braftovi + Cetuximab in BRAF V6...
  • 7/28/2025TargetRx Showcases Breakthrough Allosteric BCR::ABL1 Inhibitor for Res...
  • 7/28/2025China Approves BMS's Opdivo + Yervoy Combo for PD-L1 Positive mNSCLC
  • 7/28/2025SystImmune Files First ARC IND as ADC Pipeline Hits Double Digits
  • 7/26/2025China Leads Global Expansion in Clinical Trial Volume in Q2 2025: Glob...
  • 7/25/2025Yangtze River Pharma's Tunodafil Wins NMPA Nod
  • 7/25/2025Eisai's Lenvatinib Secures NMPA Approval in China
  • 7/25/2025AusperBio Advances AHB‑137 to Phase 3 After Green Light from China NM...
  • Page:13/22 Total number of articles:647: [First][<<] [11] [12] [13] [14] [15] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group